KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Esperion Therapeutics (ESPR) Amortizatization of Intangibles (2018 - 2023)

Esperion Therapeutics (ESPR) has disclosed Amortizatization of Intangibles for 6 consecutive years, with $73000.0 as the latest value for Q2 2023.

  • For the quarter ending Q2 2023, Amortizatization of Intangibles rose 136.68% year-over-year to $73000.0, compared with a TTM value of $73000.0 through Mar 2024, down 68.67%, and an annual FY2023 reading of $412000.0, up 247.67% over the prior year.
  • Amortizatization of Intangibles was $73000.0 for Q2 2023 at Esperion Therapeutics, down from $339000.0 in the prior quarter.
  • Across five years, Amortizatization of Intangibles topped out at $339000.0 in Q1 2023 and bottomed at -$199000.0 in Q2 2022.
  • Average Amortizatization of Intangibles over 5 years is $29857.1, with a median of $33000.0 recorded in 2019.
  • The sharpest move saw Amortizatization of Intangibles plummeted 78.95% in 2020, then surged 2266.67% in 2022.
  • Year by year, Amortizatization of Intangibles stood at $60000.0 in 2019, then crashed by 93.33% to $4000.0 in 2020, then plummeted by 400.0% to -$12000.0 in 2021, then soared by 2266.67% to $260000.0 in 2022, then tumbled by 71.92% to $73000.0 in 2023.
  • Business Quant data shows Amortizatization of Intangibles for ESPR at $73000.0 in Q2 2023, $339000.0 in Q1 2023, and $260000.0 in Q4 2022.